搜索：place:"Silver Spring"

2026/10/01

1天

八月廿一全美"JIFFY"混合粉日

健康2026/09/30@ThePinGang

FDA Vaccine Advisers Meet on 2027 Southern Hemisphere Flu Strains

FDA White Oak Campus, 10903 New Hampshire Avenue, Silver Spring, Maryland, 20993, United States

U.S. Food and Drug Administration

FDA Vaccine Advisers Meet on 2027 Southern Hemisphere Flu Strains

开始于 2026/10/01 13:00已排期可信度 75%FDA's^[1][2] meeting notice lists October 1, 2026, 9:00 a.m. - 1:00 p.m. ET and says the Committee "will convene in open session to discuss strain selection for influenza virus vaccines for the 2027 Southern Hemisphere influenza season".

FDA's Vaccines and Related Biological Products Advisory Committee meets virtually, 9:00 a.m. to 1:00 p.m. ET, to recommend influenza strains for the 2027 Southern Hemisphere vaccines, with a public FDA webcast.

1.00

2026/10/26

26天

九月十七全美驻外军人日

健康2026/09/30@ThePinGang

FDA Decision Due on GSK's Bepirovirsen for Chronic Hepatitis B

FDA White Oak Campus, 10903 New Hampshire Avenue, Silver Spring, Maryland, 20993, United States

GSK

FDA Decision Due on GSK's Bepirovirsen for Chronic Hepatitis B

开始于 2026/10/26已排期可信度 75%GSK's^[1][2] release states "October 26, 2026 assigned by FDA as PDUFA date" and its later release says a US decision is "expected from the FDA by 26 October 2026".

The FDA has set 26 October 2026 as its priority-review goal date for GSK's bepirovirsen, an antisense drug aimed at a functional cure of chronic hepatitis B after two positive phase III B-Well trials.

1.00

2027/01/06

98天

十一月廿九美国全国豆类日

健康2026/09/30@ThePinGang

FDA Decision Date for ImmunityBio's Anktiva in Papillary Bladder Cancer

FDA White Oak Campus, 10903 New Hampshire Avenue, Silver Spring, Maryland, 20993, United StatesImmunityBio

开始于 2027/01/06已排期可信度 75%ImmunityBio's^[1][2] release says the FDA "assigned a PDUFA target action date of January 6, 2027" for the supplemental BLA.

The FDA has assigned a 6 January 2027 PDUFA target date for ImmunityBio's supplemental BLA for Anktiva plus BCG in BCG-unresponsive non-muscle invasive bladder cancer with papillary disease.

1.00

与“place:"Silver Spring"”匹配的图钉

FDA Vaccine Advisers Meet on 2027 Southern Hemisphere Flu Strains

FDA Decision Due on GSK's Bepirovirsen for Chronic Hepatitis B

FDA Decision Date for ImmunityBio's Anktiva in Papillary Bladder Cancer